Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Table 3

Patterns of treatment failure and survival rate after tomotherapy.

Event	Actual incidence %	Estimated cumulative incidence %
		1 year	2 year	3 year
Overall survival		97.7	74.4	55.9
Progression-free survival		79.1	53.5	36.1
Local disease recurrence	4.7	4.7 (2)	4.7	4.7
Regional disease recurrence	11.62	0.0	10.5 (4)	15.7 (5)
Distant disease recurrence	55.81	18.7 (8)	40.2 (17)	57.9 (24)
Any progression	72.09	20.9	46.5	63.9